Ozempic is associated with lower risk of Alzheimer's disease in patients with type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wigovy, appears to reduce the risk of Alzheimer's disease in people with type 2 diabetes, according to a study published Thursday in the…